Perrigo | PRGO - Assets


Perrigo reported $7.61B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AbbVie USD 135.12B 1.35B Jun/2026
Abbott USD 110.43B 23.72B Mar/2026
Bayer EUR 107.94B 3.4B Mar/2026
Bristol-Myers Squibb USD 87.63B 1.16B Jun/2026
Coherus Biosciences USD 191.18M 74.84M Jun/2026
Corcept Therapeutics USD 888.7M 73.82M Jun/2026
Dr.Reddys Laboratories INR 575.31B 5.93B Jun/2026
Eli Lilly USD 142.28B 25.71B Jun/2026
J&J USD 201.06B 167M Jun/2026
Merck USD 128.68B 8.18B Mar/2026
Nestle CHF 128.38B 1.23B Jun/2026
Pacira USD 1.24B 35.44M Jun/2026
Perrigo USD 7.61B 373.8M Jun/2026
Pfizer USD 201.13B 6.49B Jun/2026
Phibro Animal Health USD 1.45B 39.56M Mar/2026
Prestige Brands USD 3.49B 430K Mar/2026
Reckitt Benckiser GBP 25.3B 1.11B Dec/2024
Sanofi EUR 129.06B 1.04B Jun/2026
Supernus Pharmaceuticals USD 1.43B 72.62M Jun/2026
Teva Pharmaceutical Industries USD 39.86B 183M Jun/2026
Xeris Pharmaceuticals USD 392.01M 8.49M Mar/2026
Zoetis USD 15.15B 313M Mar/2026